• babboa@lemmy.world
    link
    fedilink
    arrow-up
    2
    ·
    9 months ago

    1.6 month increased average survival. Spin it and slice the numbers however they want to, thats still pretty grim.

    • Squirrelsdrivemenuts@lemmy.world
      link
      fedilink
      arrow-up
      3
      ·
      9 months ago

      It is grim, but the average does not tell the whole story. From what I understand, it extends the life of several patients for a long time, with 4x more patients surviving three years after diagnosis. The average is low because, just as with most cancer drugs, it only helps a percentage of the patients.